Reference

1. Peipei Song, Jianjun Gao, Yoshinori Inagaki, Norihiro Kokudo, Wei Tang. Rare diseases, orphan drugs, and their regulation in Asia: Current status and future perspectives. Intractable & Rare Diseases Research. 2012; 1(1):3-9.
2. Report on Orphan Drugs in the Pipeline- presented by america's biopharmaceutical research companies. Available at: http://phrma-docs.phrma.org/sites/default /files/pdf/Rare_Diseases_2013.pdf. (access date 2-5-2023)
3. Duraiswamy Navaneetham PhD. Rare Diseases and Disorders- Estimated rare diseases population in South Asian countries . Available at: http://www.rarediseasesindia.org.
4. Rare diseases and orphan drugs J K Aronson Chairman of the Editorial Board, British Journal of Clinical Pharmacology, Br J Clin Pharmacol. 2006 Mar; 61(3): 243–245
5. Lavandeira A. Orphan drugs: legal aspects, current situation. Haemophilia. 2002;8(3):194–198. [PubMed] [Google Scholar]
6. National Organization for Rare Disorders. [26 January 2006]. http://www.rarediseases.org/search/rdblist.html.
7. Office of Rare Diseases. National Institutes of Health. Rare diseases terms. [26 January 2006]. http://rarediseases.info.nih.gov/asp/diseases/diseases.asp?this=Z#toplist.
8. Hift RJ, Meissner PN. An analysis of 112 acute porphyric attacks in Cape Town, South Africa: evidence that acute intermittent porphyria and variegate porphyria differ in susceptibility and severity. Medicine (Baltimore) 2005;84(1):48–60. [PubMed] [Google Scholar]
9. Haffner ME, Whitley J, Moses M. Two decades of orphan product development. Nat Rev Drug Discov. 2002;1(10):821–825. [PubMed] [Google Scholar]
10. Lavandeira A. Orphan drugs: Legal aspects, current situation. Haemophilia 2002;8:194-198.
11. Campos-Castello J. Orphan drugs and orphan diseases. Rev Neurol 2001;33:216-220.
12. Loizzo A, Tebano MT. Orphan diseases. Recenti Prog Med 1993;84:786-793.
13. Yamamoto T. Latent Adrenal Insufficiency: Concept, Clues to Detection, and Diagnosis. Endocr Pract. 2018 Aug;24(8):746-755. [PubMed]
14. Choudhury S, Meeran K. Glucocorticoid replacement in Addison disease. Nat Rev Endocrinol. 2018 Sep;14(9):562. [PubMed]
15. Addison’s Disease | ORD India
16. Burton C, Cottrell E, Edwards J. Addison's disease: identification and management in primary care. Br J Gen Pract. 2015 Sep;65(638):488-490. [PMC free article] [PubMed]
17. Munir S, Quintanilla Rodriguez BS, Waseem M. Addison Disease. [Updated 2022 Aug 7]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK441994/
18. (https://ordindia.in/angelman-syndrome/)
19. Sinha JK, Ghosh S, Raghunath M. Progeria: a rare genetic premature ageing disorder. Indian J Med Res. 2014 May;139(5):667-674. PMID: 25027075; PMCID: PMC4140030.
20. Baumgart DC, Sandborn WJ. Inflammatory bowel disease: clinical aspects and established and evolving treatments. The Lancet. 2007;369(9573):1641–1657. [PubMed] [Google Scholar]
21. Gryboski JD. Ulcerative colitis in children 10 years old or younger. J Pediatr Gastroenterol Nutr. 1993;17:24–31. [PubMed] [Google Scholar]
22. McGovern MM, Desnick RJ. Lysosomal storage diseases. Cecil Textbook of Medicine. In: Goldman L, editor. 21st ed. St. Louis: W.B. Saunders Company; 2000. pp. 1104–1107. [Google Scholar]
23. Thadhani R, Wolf M, West ML, Tonelli M, Ruthazer R, Pastores GM, et al. Patients with Fabry disease on dialysis in the United States. Kidney Int. 2002;61:249–255. [PubMed] [Google Scholar]
24. Wani MM, Khan I, Bhat RA, Ahmad M. Fabry's Disease: Case Series and Review of Literature. Ann Med Health Sci Res. 2016 May-Jun;6(3):193-197. doi: 10.4103/2141-9248.183935. PMID: 27398254; PMCID: PMC4924496